b2-Microglobulin (b2m) is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). The natural turnover of MHC-I gives rise to the release of b2m into plasmatic fluids and to its catabolism in the kidney. b2m dissociation from the heavy chain of the complex is a severe complication in patients receiving prolonged hemodialysis. As a consequence of renal failure, the increasing b2m concentrations can lead to deposition of the protein as amyloid fibrils. Here we characterize the His31 ! Tyr human b2m mutant, a nonnatural form of b2m that is more stable than the wild-type protein, displaying a ten-fold acceleration of the slow phase of folding. We report the 2.9A ° resolution crystal structure and the NMR characterization of the mutant b2m, focussing on selected structural features and on the molecular packing observed in the crystals. Juxtaposition of the four mutant b2m molecules contained in the crystal asymmetric unit, and specific hydrogen bonds, stabilize a compact protein assembly. Conformational heterogeneity of the four independent molecules, some of their mutual interactions and partial unpairing of the N-terminal b-strand in one protomer are in keeping with the amyloidogenic properties displayed by the mutant b2m.
ß 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation”
CORAZZA, Alessandra;ESPOSITO, Gennaro;
2004-01-01
Abstract
b2-Microglobulin (b2m) is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). The natural turnover of MHC-I gives rise to the release of b2m into plasmatic fluids and to its catabolism in the kidney. b2m dissociation from the heavy chain of the complex is a severe complication in patients receiving prolonged hemodialysis. As a consequence of renal failure, the increasing b2m concentrations can lead to deposition of the protein as amyloid fibrils. Here we characterize the His31 ! Tyr human b2m mutant, a nonnatural form of b2m that is more stable than the wild-type protein, displaying a ten-fold acceleration of the slow phase of folding. We report the 2.9A ° resolution crystal structure and the NMR characterization of the mutant b2m, focussing on selected structural features and on the molecular packing observed in the crystals. Juxtaposition of the four mutant b2m molecules contained in the crystal asymmetric unit, and specific hydrogen bonds, stabilize a compact protein assembly. Conformational heterogeneity of the four independent molecules, some of their mutual interactions and partial unpairing of the N-terminal b-strand in one protomer are in keeping with the amyloidogenic properties displayed by the mutant b2m.File | Dimensione | Formato | |
---|---|---|---|
Rosano_JMB_2004.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Non pubblico
Dimensione
2.39 MB
Formato
Adobe PDF
|
2.39 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.